Patient-Reported Outcomes after Laparoscopic Ventral Hernia Repair

2016 ◽  
Vol 82 (6) ◽  
pp. 550-556 ◽  
Author(s):  
Johnathon M. Aho ◽  
Ahmad Nourallah ◽  
Mario J. Samaha ◽  
Ryan M. Antiel ◽  
Sean C. Dupont ◽  
...  
Keyword(s):  
Hernia Repair ◽  
Ventral Hernia ◽  
Patient Reported Outcomes ◽  
Ventral Hernia Repair ◽  
Well Being ◽  
Pain Scale ◽  
Analog Scale ◽  
Self Assessment ◽  
Patient Reported ◽  
Over Time

Approximately 350,000 ventral hernia repairs are performed in the United States each year. Patients expect fast recovery after laparoscopic ventral hernia repair (LVHR) and undisturbed postoperative quality of life (QOL). We examined the utility of a brief, validated 10-point Linear Analog Self-Assessment coupled with the Visual Analog Scale pain scale to discern risk factors for decreased postoperative QOL. Between January 2011 and May 2013, we prospectively assessed patient-reported outcomes for patients who underwent LVHR. Visual Analog Scale pain scale and Linear Analog Self-Assessment items were recorded preoperatively and postoperatively at four hours, one day, and seven days. Eighteen patients were included, 11 were female (61%) and 8 > 60 years old (44%). Patient-reported fatigue increased clinically and statistically from baseline over time ( P = 0.007) as did pain ( P < 0.001). There was a statistically significant difference in QOL scores over time by gender with women reporting worse scores than men ( P = 0.001). In conclusion, our study detected significant changes from baseline in both fatigue and pain over the seven days after LVHR. Age is associated with postoperative differences in physical well-being. Gender is associated with differences in postoperative course in QOL and physical well-being.

Patient-Reported Outcomes Following Ventral Hernia Repair: Designing a Qualitative Assessment Tool

2017 ◽  
Vol 11 (2) ◽  
pp. 225-234 ◽  
Author(s):  
Martin J. Carney ◽  
Kate E. Golden ◽  
Jason M. Weissler ◽  
Michael A. Lanni ◽  
Andrew R. Bauder ◽  
...  
Keyword(s):  
Hernia Repair ◽  
Ventral Hernia ◽  
Patient Reported Outcomes ◽  
Ventral Hernia Repair ◽  
Assessment Tool ◽  
Qualitative Assessment ◽  
Patient Reported

Comparison of Follow-Up Methods for Long-Term Patient Reported Outcomes after Ventral Hernia Repair

2016 ◽  
Vol 223 (4) ◽  
pp. e105
Author(s):  
Nishant Ganesh Kumar ◽  
Adil A. Faqih ◽  
Richard A. Pierce ◽  
Richard S. Miller ◽  
Kenneth W. Sharp ◽  
...  
Keyword(s):  
Hernia Repair ◽  
Ventral Hernia ◽  
Patient Reported Outcomes ◽  
Ventral Hernia Repair ◽  
Patient Reported

Using Quality Improvement Principles to Enhance Long-Term Completion of Patient-Reported Outcomes after Ventral Hernia Repair

2017 ◽  
Vol 224 (2) ◽  
pp. 172-179 ◽  
Author(s):  
Nishant Ganesh Kumar ◽  
Adil A. Faqih ◽  
Michael P. Feng ◽  
Richard S. Miller ◽  
Richard A. Pierce ◽  
...  
Keyword(s):  
Quality Improvement ◽  
Hernia Repair ◽  
Ventral Hernia ◽  
Patient Reported Outcomes ◽  
Ventral Hernia Repair ◽  
Patient Reported

Opioid Use After Inguinal and Ventral Hernia Repair

2020 ◽  
Vol 86 (8) ◽  
pp. 965-970
Author(s):  
Jessica L. Millard ◽  
Robyn Moraney ◽  
Jordan C. Childs ◽  
Joseph A. Ewing ◽  
Alfredo M. Carbonell ◽  
...  
Keyword(s):  
Inguinal Hernia ◽  
Incisional Hernia ◽  
Hernia Repair ◽  
Ventral Hernia ◽  
Inguinal Hernia Repair ◽  
Patient Reported Outcomes ◽  
Opioid Use ◽  
Patient Reported ◽  
Primary Ventral Hernia ◽  
Ventral Hernias

Background Recent data on opioid consumption indicate that patients typically require far less than is prescribed. Prisma Health Upstate Hernia Center adopted standardized postoperative prescribing after hernia repair and began tracking patient-reported opioid utilization. The aim of this study is to evaluate patient opioid use after hernia repair in order to guide future prescribing. Methods All patients who underwent primary ventral (umbilical and epigastric), incisional, and inguinal hernia repair between February and May 2019 were reviewed. Patients reported the number of opioid pills taken at their first postoperative visit and documented either in the progress note or in the Americas Hernia Society Quality Collaborative (AHSQC) patient-reported outcomes (PRO) questionnaire. All demographic, operative, and outcomes data were captured prospectively in the AHSQC. Opioid use reported as milligram morphine equivalents (MME). Results A total of 162 surgeries were performed during the study period, and 107 had patient-reported opioid use for analysis. Inguinal hernia repair was performed in 36 patients, 10 primary ventral hernia repairs, and 61 incisional hernia repairs. No opioid use was reported in 63.9% of inguinal hernias, 60% of primary ventral hernias, and 20% of incisional hernias. Inguinal hernia patients consumed a mean of 10.5 MME, primary ventral patients 11 MME, and incisional hernia patients 78.5 MME. Conclusion Patients require little to no opioid after primary ventral or inguinal hernia repair and opioid-free surgery is feasible. Incisional hernia is more heterogenous, but the majority of patients still required less opioid than previously thought.

Patient reported outcomes after incisional hernia repair—establishing the ventral hernia recurrence inventory

2016 ◽  
Vol 212 (1) ◽  
pp. 81-88 ◽  
Author(s):  
Rebeccah B. Baucom ◽  
Jenny Ousley ◽  
Irene D. Feurer ◽  
Gloria B. Beveridge ◽  
Richard A. Pierce ◽  
...  
Keyword(s):  
Incisional Hernia ◽  
Hernia Repair ◽  
Ventral Hernia ◽  
Patient Reported Outcomes ◽  
Incisional Hernia Repair ◽  
Hernia Recurrence ◽  
Patient Reported

scholarly journals A Prospective, Single Arm, Multi-Center Study Evaluating the Clinical Outcomes of Ventral Hernias Treated with OviTex® 1S Permanent Reinforced Tissue Matrix: The BRAVO Study 12-Month Analysis

2021 ◽  
Vol 10 (21) ◽  
pp. 4998
Author(s):  
George DeNoto ◽  
Eugene P. Ceppa ◽  
Salvatore J. Pacella ◽  
Michael Sawyer ◽  
Geoffrey Slayden ◽  
...  
Keyword(s):  
Hernia Repair ◽  
Ventral Hernia ◽  
Ventral Hernia Repair ◽  
Hernia Recurrence ◽  
Patient Reported ◽  
Multi Center Study ◽  
Tissue Matrix ◽  
Ventral Hernias ◽  
Center Study

Background: Conflicting results from previous studies have led to dissent over whether surgical mesh is safe and effective in ventral hernia repair. A newer class of mesh known as a reinforced tissue matrix, combining a biologic scaffold and minimal polymer reinforcement, offers promise in reducing inflammatory response and increasing abdominal wall support. This study sought to assess the clinical utility of a reinforced tissue matrix (OviTex) in ventral hernia repair 12 months after implantation. Methods: This is a prospective, single-arm, multi-center study to evaluate the clinical performance of OviTex® 1S Permanent (OviTex) in the repair of primary or recurrent ventral hernias (VH) in consecutive patients (ClinicalTrials.gov/NCT03074474). The rate of surgical site occurrences (SSOs) was evaluated 90 days post-surgery as the primary endpoint. Hernia recurrence and the incidence of postoperative events were evaluated between three and 12 months as secondary endpoints. The incidence of other complications and patient-reported outcomes were also recorded. Results: Ninety-two (92) patients were enrolled in the study, of whom seventy-six (76) reached the 12-month follow-up. All patients were at least 18 years of age with a BMI of <40 kg/m2. Hernia defects were <20 × 20 cm, classified as class I–III according to the CDC wound classification system. Of the 76 patients who reached 12-month follow-up, twenty-six (34%) had previous VH repairs and thirteen (17%) had previous surgical infection. Sixty (79%) had factors known to increase the risk of recurrence. Twenty patients (26%) experienced SSOs, with ten (13%) requiring procedural intervention. Two of the 75 patients (2.7%) experienced a recurrence. Conclusions: The low rate of hernia recurrence and SSOs requiring intervention illustrates the potential that reinforced tissue matrices, and OviTex 1S, in particular, have to improve outcomes in VH repairs. Follow-up to 24 months is ongoing.

scholarly journals P089 THE IMPACT OF VENTRAL HERNIA REPAIR ON PATIENT-REPORTED QUALITY OF LIFE: IDENTIFYING FACTORS ASSOCIATED WITH IMPROVEMENT

2021 ◽  
Vol 108 (Supplement_8) ◽  
Author(s):  
Martin Morris ◽  
Viren Patel ◽  
Adrienne Christopher ◽  
Robyn Broach ◽  
John Fischer
Keyword(s):  
Quality Of Life ◽  
Hernia Repair ◽  
Ventral Hernia ◽  
Ventral Hernia Repair ◽  
Abdominal Hernia ◽  
Factors Associated ◽  
Patient Reported ◽  
The Impact

Abstract Aim Assessing pre- and postoperative quality of life (QoL) is essential to quantify the magnitude of improvement in disease burden after ventral hernia repair (VHR). Here, we identify patient and operative factors associated with QoL improvement after VHR. Material and Methods Patients that underwent VHR by a single surgeon were retrospectively identified and included if they had minimum 1 year of follow-up, and completed pre- and postoperative Abdominal Hernia-Q (AHQ) questionnaires. Patients were divided into quintiles based on absolute pre- to postoperative improvement in AHQ score. Chi-squared and fisher’s exact tests were used for categorical data, and Student’s t-test for continuous data, as appropriate. Results Compared to the lowest quintile (n = 27, follow-up 32.6 months, mean improvement 3.24 [SD 10.4]), patients in the highest quintile (n = 26, follow up 23.9 months, mean improvement 66.3 [SD 12.1]) were female (76.9% vs 37.0%, p = 0.005) with a greater number of previous hernia repairs (mean 2.12 vs. 0.78, p &lt; 0.005) and previous abdominal surgeries (mean 4.0 vs 2.0, p &lt; 0.001). Patients with greater improvement also had higher incidences of delayed healing (42.3% vs 7.41%), required more office visits (5.54 vs 3.89), and had higher inpatient costs ($30,084 USD vs. $16,886, all p &lt; 0.05). No significant differences were seen in terms of race, ethnicity, body mass index, age, length of stay, Clavien-Dindo scores, hernia recurrence, or other postoperative complications. Conclusions Despite increased preoperative risk and healthcare burden, some of the most significant QoL improvement after VHR is demonstrated in patients with complex repairs and recoveries. This indicates the global utility of VHR regardless of patient demographics and complicating perioperative factors.

scholarly journals Patient-Reported Outcomes and Quality of Life after Treatment for Choroidal Melanoma

2019 ◽  
Vol 5 (6) ◽  
pp. 402-411 ◽  
Author(s):  
Bertil Damato ◽  
Laura Hope-Stone ◽  
Bruce Cooper ◽  
Steve Brown ◽  
Heinrich Heimann ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Metastatic Disease ◽  
Tumor Recurrence ◽  
Patient Reported Outcomes ◽  
Choroidal Melanoma ◽  
Well Being ◽  
Visual Disability ◽  
Patient Reported ◽  
Over Time

Background/Aims: Patients with choroidal melanoma can develop psychological morbidity because of visual disability, pain, facial deformity, and fears of metastatic disease. The aim of this study was to report on the prevalence of symptoms, moods, and well-being after radiotherapy or enucleation for choroidal melanoma and how these outcomes changed over time. Methods: Participants were mailed questionnaires approximately 6 months following treatment, then annually on every anniversary of their treatment. Results: Soon after enucleation, patients experienced visual difficulties because of loss of stereopsis and visual field and were concerned about their appearance and about metastatic disease. After radiotherapy, patients were more concerned about local tumor recurrence and more troubled by diplopia and headache. Over time, visual difficulties diminished after enucleation but increased in patients who had received radiotherapy, with concerns about metastasis, loss of health, and tumor recurrence diminishing in both groups. Anxiety tended to diminish whereas depression increased, especially after enucleation. Emotional well-being improved after both kinds of treatment, whereas functional and physical well-being diminished after enucleation but improved after radiotherapy. Self-reported quality of life diminished equally with both kinds of treatment. Conclusion: The findings of this study should help physicians understand what patients tend to feel after treatment for choroidal melanoma.

Sign in / Sign up

Export Citation Format

Share Document